Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

With $3bn Viela Acquisition, Horizon Builds A Pipeline

01 Feb 2021

• By Jessica Merrill

building construction — Horizon is growing with the acquisition of Viela • Source: Shuterstock

Related Content

Keeping Track: US FDA Approvals Include Novel Agents Zepzelca And Uplizna, Biosimilar Nyvepria, Follow-On Semglee

16 Jun 2020

IPO Update: 35 Biopharmas Provide -6.1% Average Return; New Offerings Feel Stock Market Impact

03 Oct 2019

2020 Drug Launches, Like Everything, Will Be Remembered For COVID-19

02 Jan 2021

Related Companies

Horizon Therapeutics plc

Viela Bio, Inc.

AstraZeneca PLC

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.